Guidelines for Management of Ischaemic Stroke 2008 - ESO
Guidelines for Management of Ischaemic Stroke 2008 - ESO
Guidelines for Management of Ischaemic Stroke 2008 - ESO
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>ESO</strong>-<strong>Guidelines</strong> <strong>for</strong> <strong>Management</strong> <strong>of</strong> <strong>Ischaemic</strong> <strong>Stroke</strong> <strong>2008</strong><br />
Subjects with an elevated body mass index are recommended to take a weight-<br />
reducing diet (Class III, Level B)<br />
Antioxidant vitamin supplements are not recommended (Class I, Level A)<br />
Hormone replacement therapy is not recommended <strong>for</strong> the primary prevention <strong>of</strong><br />
stroke (Class I, Level A)<br />
A healthy lifestyle, consisting <strong>of</strong> abstinence from smoking, low-normal body mass<br />
index, moderate alcohol consumption, regular exercise and healthy diet, is<br />
associated with a reduction in ischaemic stroke (RR 0.29; 95% CI 0.14-0.63) [204].<br />
High blood pressure<br />
A high (> 120/80 mmHg) blood pressure (BP) is strongly and directly related to<br />
vascular and overall mortality without evidence <strong>of</strong> any threshold [205]. Lowering BP<br />
substantially reduces stroke and coronary risks, depending on the magnitude <strong>of</strong> the<br />
reduction [206-208]. BP should be lowered to 140/85 mmHg or below [209];<br />
antihypertensive treatment should be more aggressive in diabetic patients (see<br />
below) [210]. A combination <strong>of</strong> two or more antihypertensive agents is <strong>of</strong>ten<br />
necessary to achieve these targets.<br />
Most studies comparing different drugs do not suggest that any class is superior<br />
[206, 207, 211]. However, the LIFE (Losartan Intervention <strong>for</strong> Endpoint reduction in<br />
hypertension) trial found that losartan was superior to atenolol in hypertensive<br />
patients with left ventricular hypertrophy (NNT to prevent stroke 270) [212, 213].<br />
Similarly, the ALLHAT (Antihypertensive and Lipid-Lowering treatment to prevent<br />
Heart Attack) trial found that chlorthalidone was more effective than amlodipine and<br />
lisinopril [214]. Beta-blockers may still be considered an option <strong>for</strong> initial and<br />
subsequent antihypertensive treatment [209]. In elderly subjects, controlling isolated<br />
systolic hypertension (systolic blood pressure >140 mmHg and diastolic blood<br />
pressure